Showing results (261-270 of 297) with videos related to

Sort By:
Pageof 30
The Lancet. Rheumatology|January 30, 2024
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trialMichelle L M Mulder, Johanna E Vriezekolk, Tamara W van Hal, et al.
Trials|September 5, 2022
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trialDafna D Gladman, Philip J Mease, Paul Bird, et al.
The Journal of Rheumatology|July 7, 2023
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working GroupYing-Ying Leung, William Tillett, Maarten de Wit, et al.
The Journal of Rheumatology|February 12, 2010
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008Laura C Coates, Dennis M McGonagle, Richard Hodgson, et al.
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
The Journal of Rheumatology|May 2, 2021
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic ArthritisProton Rahman, Christopher T Ritchlin, Philip S Helliwell, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network MeetingRobin Waxman, Carmel Stober, Deepak R Jadon, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trialPhilip Mease, Laura C Coates, Philip S Helliwell, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Pageof 30